Skip to content
Not evaluated by SAHPRA · Research & educational information only · Nothing on this site is for sale · Not medical advice · Consult a healthcare professional
Not evaluated by SAHPRA. Research & educational information only — nothing is for sale; not intended to diagnose, treat, cure or prevent any disease.
← Back to catalogue
Mind & MoodResearch vialnootropicfocusbdnfstroke-recoveryresearch

Semax

ACTH(4-10) analogue for cognition and BDNF

Format
Research vial
Strength / pack
30mg vial
Category
Mind & Mood
Raises hippocampal BDNFDolotov 2006: a single 50 µg/kg intranasal dose in rats produced a 1.4-fold rise in BDNF protein, 3-fold rise in BDNF mRNA, and increased trkB phosphorylation.
Stroke-recovery signalRussian clinical work in ischaemic stroke reports faster Barthel-index recovery and elevated plasma BDNF on intranasal 6,000 µg/day across two 10-day courses.
Attention and short-term memoryHealthy-volunteer studies report improvements in attention and short-term memory after intranasal dosing.
Intranasal deliveryConvenient nasal-spray administration avoids injection.
Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro), an analogue of ACTH(4-10) developed in the 1980s at the Institute of Molecular Genetics in Moscow. It is on the Russian Federation's List of Vital and Essential Drugs and is prescribed there for stroke recovery and cognitive complaints. Outside Russia it remains unapproved and largely unstudied in Western trials.
Publisher
Elegant Slimming · Mokopane, Limpopo, South Africa
Research library · nothing on this site is for sale.
Regulatory
This compound has not been evaluated by the South African Health Products Regulatory Authority (SAHPRA).
For information purposes only — not intended to diagnose, treat, cure or prevent any disease.